(Q37891602)

24 August 2017

title

Paralytic poliomyelitis associated with Sabin monovalent and bivalent oral polio vaccines in Hungary (English)

1 reference

24 August 2017

1 reference

paralytic poliomyelitis

1 reference

1 reference

7

Olen M Kew

1 reference

24 August 2017

author name string

Concepción F Estívariz

1

1 reference

24 August 2017

Zsuzsanna Molnár

2

1 reference

24 August 2017

Linda Venczel

3

1 reference

24 August 2017

Beatrix Kapusinszky

4

1 reference

24 August 2017

James A Zingeser

5

1 reference

24 August 2017

Galina Y Lipskaya

6

1 reference

24 August 2017

György Berencsi

8

1 reference

24 August 2017

Agnes Csohán

9

1 reference

24 August 2017

language of work or name

English

0 references

publication date

17 June 2011

1 reference

American Journal of Epidemiology

24 August 2017

published in

1 reference

24 August 2017

volume

174

1 reference

24 August 2017

issue

3

1 reference

24 August 2017

page(s)

316-325

1 reference

Polio eradication: the OPV paradox

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWR070

Sabin monovalent oral polio vaccines: review of past experiences and their potential use after polio eradication

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWR070

Monovalent type 1 oral poliovirus vaccine in newborns

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWR070

Vaccine-Associated Paralytic Poliomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWR070

Epidemiology of poliomyelitis in the United States one decade after the last reported case of indigenous wild virus-associated disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWR070

The vaccine origin of the 1968 epidemic of type 3 poliomyelitis in Poland.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWR070

Characterisation of L cells expressing the human poliovirus receptor for the specific detection of polioviruses in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWR070

Molecular evolution of a type 1 wild-vaccine poliovirus recombinant during widespread circulation in China

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWR070

Molecular characterization of poliovirus isolates from children who contracted vaccine-associated paralytic poliomyelitis (VAPP) following administration of monovalent type 3 oral poliovirus vaccine in the 1960s in Hungary

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWR070

Shedding of sabin poliovirus Type 3 containing the nucleotide 472 uracil-to-cytosine point mutation after administration of oral poliovirus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWR070

VACCINE-DERIVED POLIOVIRUSES AND THE ENDGAME STRATEGY FOR GLOBAL POLIO ERADICATION *

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWR070

Vaccine policy changes and epidemiology of poliomyelitis in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWR070

Relation of poliomyelitis virus types to clinical disease and geographic distribution: a preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWR070

Increased neurovirulence associated with a single nucleotide change in a noncoding region of the Sabin type 3 poliovaccine genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWR070

21 January 2018

Identifiers

DOI

10.1093/AJE/KWR070

1 reference

24 August 2017

1 reference